Millennium Pharmaceuticals, Inc., a subsidiary of Takeda Pharmaceutical Company, is a prominent player in the biotechnology industry, headquartered in the United States. Founded in 1993, the company has made significant strides in oncology, focusing on innovative therapies for cancer treatment. With a strong presence in North America and Europe, Millennium is renowned for its commitment to advancing cancer care through cutting-edge research and development. The company’s flagship products, including Velcade and Ninlaro, are distinguished by their unique mechanisms of action, offering new hope to patients with multiple myeloma and other malignancies. Millennium's dedication to scientific excellence has positioned it as a leader in the oncology market, with numerous accolades recognising its contributions to cancer therapeutics. Through its ongoing efforts, Millennium Pharmaceuticals continues to shape the future of cancer treatment, striving to improve patient outcomes worldwide.
We don't have data for Millennium Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company